Cyclin-dependent kinase inhibitors for cancer therapy: a patent review (2009 – 2014)

Taylor and Francis Group, Expert Opinion on Therapeutic Patents, 9(25), p. 953-970, 2015

Journal article published in 2015 by Veronika Malínková, Jakub Vylíčil, Vladimír Kryštof

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by